The Botox Paradox: How Rising Drug Costs and Reimbursement Failures Threaten Access to Botulinum Toxin Therapy in Neurology
Patricio S Espinosa · 2026
Read The Botox Paradox: How Rising Drug Costs and Reimbursement Failures Threaten Access to Botulinum Toxin Therapy in Neurology by Patricio S Espinosa (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13397860.txt.
Description
Patricio S Espinosa writes a 2026 commentary on a payment paradox around botulinum toxin treatment in neurology. The drug, sold for medical use as Botox, ranks among the best therapies for chronic migraine, neck dystonia, eyelid spasm and spasticity. Yet rising purchase prices, wasted part-used vials, weak insurer payments and heavy paperwork now push small neurology practices toward loss.
Blending published evidence with his own private practice experience, Espinosa shows how the same drug profits handsomely in beauty clinics while losing money when it treats disabling disease. Careful patient choice and proven-use rules matter, he argues, but cannot fix a payment structure that punishes the clinics offering the treatment. Access for patients, he warns, is what fails next.
Catalog record
| CREATOR | Patricio S Espinosa |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 12404 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |